“…Evidence for the involvement of IGF-1 signaling in tumorigenesis comes from several distinct observations as follows: (i) tumors originating from breast (Yee et al, 1989), colon (Tricoli et al, 1986), and lung (Minuto et al, 1986) in humans, and skin in mouse (Rho et al, 1996) have been shown to overexpress either IGF-1, IGF-1r or both; (ii) overexpression of IGF-1r confers ligand dependent transformation in cultured cells (Kaleko et al, 1990); (iii) IGF-1 expression is elevated in cells carrying an activated p21 Ha-ras (Dawson et al, 1995); (iv) IGF-1 has been shown to induce the expression of other mitogenic growth factors (Vardy et al, 1995); and (v) ®broblasts obtained from IGF-1r null mice were highly resistant to transformation by SV40-T antigen, activated Ha-ras, or a combination of both, while re-introduction of wild-type IGF-1r again conferred susceptibility to transformation (Sell et al, 1993 andSell et al, 1994).…”